We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
Cap. Flow
-$1.07B
Cap. Flow %
-18.41%
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$31.9M
2
GEHC icon
GE HealthCare
GEHC
+$31.5M
3
IBRX icon
ImmunityBio
IBRX
+$20.9M
4
GTLB icon
GitLab
GTLB
+$14.8M
5
VSTM icon
Verastem
VSTM
+$13.4M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$52.3M
2
SPB icon
Spectrum Brands
SPB
+$49.4M
3
SMPL icon
Simply Good Foods
SMPL
+$46.6M
4
SAM icon
Boston Beer
SAM
+$42M
5
DPZ icon
Domino's
DPZ
+$41.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Consumer Discretionary 5.85%
3 Technology 4.99%
4 Consumer Staples 1.48%
5 Communication Services 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WDAY icon
51
Workday
WDAY
$39.6B
$15.4M 0.27%
64,016
-39,870
-38% -$9.71M
ANGO icon
52
AngioDynamics
ANGO
$611M
$15.2M 0.26%
1,527,815
-566,185
-27% -$5.54M
VYGR icon
53
Voyager Therapeutics
VYGR
$183M
$14.9M 0.26%
4,800,000
-636,000
-12% -$2.05M
GTLB icon
54
GitLab
GTLB
$5.83B
$14.6M 0.25%
+323,559
New +$14.8M
AUPH icon
55
Aurinia Pharmaceuticals
AUPH
$1.91B
$13.8M 0.24%
1,629,600
-3,370,400
-67% -$27M
PRTA icon
56
Prothena Corp
PRTA
$425M
$13.6M 0.23%
2,236,000
+40,000
+2% +$300K
NPCE icon
57
Neuropace
NPCE
$439M
$12.8M 0.22%
1,152,335
-1,279
-0.1% -$16K
ISRG icon
58
Intuitive Surgical
ISRG
$127B
$12.5M 0.22%
22,995
-6,063
-21% -$3.17M
DT icon
59
Dynatrace
DT
$12.9B
$12.4M 0.21%
223,988
-26,012
-10% -$1.3M
HUBS icon
60
HubSpot
HUBS
$12.2B
$12.3M 0.21%
22,104
+10,067
+84% +$5.9M
TMO icon
61
Thermo Fisher Scientific
TMO
$213B
$12.1M 0.21%
+29,964
New +$12.5M
AXGN icon
62
Axogen
AXGN
$2.27B
$12.1M 0.21%
1,111,319
+573,041
+106% +$7.51M
TOST icon
63
Toast
TOST
$18.7B
$11.8M 0.2%
265,504
-598,219
-69% -$23.5M
IRWD icon
64
Ironwood Pharmaceuticals
IRWD
$696M
$11.6M 0.2%
16,150,000
+2,450,000
+18% +$1.92M
JNJ icon
65
Johnson & Johnson
JNJ
$618B
$11.5M 0.2%
+75,218
New +$11.6M
ENR icon
66
Energizer
ENR
$1.44B
$10.8M 0.19%
536,000
-592,144
-52% -$14.2M
ROST icon
67
Ross Stores
ROST
$80.5B
$10.3M 0.18%
81,018
+6,332
+8% +$879K
SXT icon
68
Sensient Technologies
SXT
$5.26B
$10.2M 0.18%
103,805
-446,022
-81% -$39.9M
CENTA icon
69
Central Garden & Pet Co Class A
CENTA
$2.37B
$10.1M 0.17%
324,000
-701,085
-68% -$21.9M
NVDA icon
70
NVIDIA
NVDA
$4.86T
$9.8M 0.17%
62,000
-44,110
-42% -$5.55M
TSM icon
71
TSMC
TSM
$2.1T
$9.29M 0.16%
41,000
-21,000
-34% -$3.89M
LTH icon
72
Life Time Group Holdings
LTH
$10.1B
$9.14M 0.16%
+301,290
New +$8.94M
VSTM icon
73
Verastem
VSTM
$510M
$8.86M 0.15%
+2,136,000
New +$13.4M
PATH icon
74
UiPath
PATH
$6.61B
$8.86M 0.15%
692,000
-1,107,689
-62% -$13.3M
UBER icon
75
Uber
UBER
$143B
$8.56M 0.15%
91,722
-144,025
-61% -$11.9M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.

  • Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
  • Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
  • Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
  • Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
  • Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
  • Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
  • Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.